Browse by author
Lookup NU author(s): Zak Gamie, Dr Kenneth RankinORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. Primary patellar neoplasms are rare, comprising 0.12% of primary bone tumours; thus, no standardised treatment related to staging exists. 70%-90% of primary patellar neoplasms are benign or intermediate with giant cell tumour (GCT) being the most common. GCTs are locally aggressive, have a high recurrence rate and metastasise in 1%-2%. We report the case of a 23-year-old man with histologically confirmed recurrent GCT of the patella to demonstrate that aggressive surgical management options described in the literature, such as patellectomy with or without complex reconstruction, may be excessive and cause patients undue morbidity. Initially, the patient underwent intralesional curettage with excellent recovery, but presented again with a local recurrence within a year. A further definitive operation was performed which included excision of the inferior pole followed by curettage of the patellar body and artificial bone grafting. The patient made a good recovery and at 5-year follow-up has maintained good function.
Author(s): Morris TM, Gamie Z, Ghosh KM, Rankin KS
Publication type: Article
Publication status: Published
Journal: BMJ Case Reports
Year: 2018
Volume: 2018
Online publication date: 14/02/2018
Acceptance date: 31/01/2018
ISSN (electronic): 1757-790X
Publisher: BMJ Publishing Group
URL: https://doi.org/10.1136/bcr-2017-221275
DOI: 10.1136/bcr-2017-221275
Altmetrics provided by Altmetric